Barclays sets USD 40.00 target for Amrize stock

Published on 10/21/2026 at 09:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Barclays set a USD 40.00 target on October 16, 2026. Amrize stock costs EUR 34.61 on October 21, 2026, ahead of Q3 results.

Analyst caution and reporting dates

Barclays maintained a Hold rating and set a USD 40.00 target on October 16, 2026.
Second-quarter revenue reached USD 3.49 billion and net profit was USD 478.00 million.
Amrize stock was trading at EUR 34.61 at 9:01 a.m. CEST at Lang & Schwarz on October 21, 2026.
Third-quarter results are scheduled for October 28, 2026, followed by a webcast on October 29, 2026.

Amrize, CH1430134226, Illustration mit AI erstellt.

Amrize (ISIN CH1430134226) was trading at EUR 34.61 at Lang & Schwarz at 9:01 a.m. CEST on October 21, 2026. Barclays maintained a Hold rating and set a USD 40.00 target on October 16, 2026, according to Markets Insider.

Analysts weigh margin pressure

The Barclays view came as analysts assessed cost pressure ahead of Amrize's third-quarter report. Markets Insider reported on October 13, 2026 that JPMorgan cut its target from USD 52.00 to USD 48.00 while retaining a Neutral rating. The note cited diesel costs, limited pricing realization and subdued demand as risks to margins.

Amrize's second-quarter revenue was USD 3.49 billion for the quarter ended June 30, 2026, while net profit reached USD 478.00 million, according to Markets Insider. The comparison with the prior-year quarter was USD 3.22 billion in revenue and USD 429.00 million in net profit.

Three analyst steps set the tone

On October 9, 2026, RBC Capital cut its target from USD 48.00 to USD 32.00 and kept an Underperform rating, as Investing.com reported. On October 13, 2026, JPMorgan lowered its target to USD 48.00 from USD 52.00. On October 16, 2026, Barclays set its USD 40.00 target while maintaining Hold.

What comes next for Amrize?

Amrize plans to release third-quarter 2026 results after the U.S. market closes on October 28, 2026. The company scheduled its results webcast for 7:30 a.m. Central Time on October 29, 2026, according to MarketScreener. Those dates give investors the next checkpoint for revenue, earnings and cost trends.

NYSE valuation remains mixed

Amrize's primary listing is on the NYSE, where the last available quote was USD 38.83 on October 20, 2026 at 4:00 p.m. EDT. The same market reference showed a 52-week range of USD 35.78 to USD 65.94 and a market capitalization of USD 21.2 billion.

The further course of trading is shown by the continuously updated real-time quote of Amrize stock.